2,023
Views
40
CrossRef citations to date
0
Altmetric
Original Articles

Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities

, , , , , , & show all
Pages 412-422 | Received 15 Apr 2020, Accepted 19 Apr 2020, Published online: 27 May 2020

References

  • Norden AGW, Lapsley M, Lee PJ, et al. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int. 2001;60:1885–1892.
  • Lund U, Rippe A, Venturoli D, et al. Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Amer J Physiol Renal Physiol. 2003;284:F1226–34.
  • Tenstad O, Roald AB, Grubb A, et al. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996;56:409–414.
  • Corcoran AC, Beattie J, Page IH. A grass polysaccharide as an index of decreased glomerular permeability in renal diseases. J Clin Invest. 1950;29:806–807.
  • Beattie J, Corcoran AC. Renal clearances of grass polysaccharide: observations on glomerular porosity and on the relation of this function to proteinuria in renal disease. J Clin Invest. 1952;31:445–450.
  • Roberts M, Lindheimer MD, Davison JM. Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol. 1996;270:F338–43.
  • Oberbauer R, Nenov V, Weidekamm C, et al. Reduction in mean glomerular pore size coincides with the development of large shunt pores in patients with diabetic nephropathy. Exp Nephrol. 2001;9:49–53.
  • Rippe C, Asgeirsson D, Venturoli D, et al. Effects of glomerular filtration rate on Ficoll sieving coefficients (theta) in rats. Kidney Int. 2006;69:1326–1332.,
  • Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest. 2001;61:575–580.
  • Strevens H, Wide-Swensson D, Torffvit O, et al. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002;62:141–147.
  • Grubb A, Lindström V, Jonsson M, et al. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: “Shrunken pore syndrome. Scand J Clin Lab Invest. 2015;75:333–340.
  • Rippe B, Haraldsson B. Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev. 1994;74:163–219.
  • Dardashti A, Nozohoor S, Grubb A, et al. Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting. Scand J Clin Lab Invest. 2016;76:74–81.
  • Herou E, Dardashti A, Nozohoor S, et al. The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio. Scand J Clin Lab Invest. 2019;79:167–173.
  • Sällman-Almén M, Björk J, Nyman U, et al. Shrunken pore syndrome is associated with increased levels of atherosclerosis-promoting proteins. Kidney Int Rep. 2019;4:67–79.
  • Purde MT, Nock S, Risch L, et al. Ratio of cystatin C and creatinine-based estimates of the glomerular filtration rate predicts mortality in healthy seniors independent of kidney function. Scand J Clin Lab Invest. 2016;76:341–343.
  • Purde MT, Nock S, Risch L, et al. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. 2016;169:80–90.
  • Christensson A, Grubb A, Molvin J, et al. The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population – the HARVEST study. Scand J Clin Lab Invest. 2016;76:568–574.
  • Grubb A, Horio M, Hansson LO, et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate using seven assays standardized to the international calibrator. Clin Chem. 2014;60:974–986.
  • Krutzén E, Bäck SE, Nilsson-Ehle I, et al. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J. Lab. Clin. Med. 1984;104:955–961.
  • Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: Iohexol clearance and cystatin C serum concentration. Kidney Int. 1994;46:S17–S9.
  • Soveri I, Berg UB, Björk J, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64:411–424.
  • Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921–1926.
  • Björk J, Grubb A, Larsson A, et al. Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden. Clin Chem Lab Med. 2015;53:403–414.
  • Nyman U, Grubb A, Larsson A, et al. The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population. Clin Chem Lab Med. 2014;52:815–824.
  • Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–29.
  • Pottel H, Delanaye P, Schaeffner E, et al. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 2017;32:497–507.
  • Grubb A, Nyman U, Björk J. Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine. Scand J Clin Lab Invest. 2012;72:73–77.
  • Björk J, Grubb A, Gudnason V, et al. Comparison of glomerular filtration rate estimating equations derived from creatinine and cystatin C: validation in the Age, Gene/Environment Susceptibility-Reykjavik elderly cohort. Nephrol Dial Transplant. 2018;33:1380–1388.
  • Björk J, Nyman U, Berg U, et al. Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre. Pediatr Nephrol. 2019;34:1087–1098.
  • Leion F, Hegbrant J, den Bakker E, et al. Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome. Scand J Clin Lab Invest. 2017;77:338–344.
  • Ma YC, Zuo L, Chen JH, et al. Chinese eGFR Investigation Collaboration. Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int. 2007;72:1535–1542.
  • Grubb A. Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check. Scand J Clin Lab Invest. 2010;70:65–70.
  • Tools for calculating robust cystatin C- and creatinine-based estimates of relative GFR and absolute GFR from relative GFR as well as for diagnosing shrunken pore syndrome. Accessed 2020 Apr. Available from: www.egfr.se/eGFRen.html
  • Jernberg T, Lindahl B, James S, et al. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation. 2004;110:2342–2348.
  • Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060.
  • Peralta C, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305:1545–1552.
  • Shlipak MG, Matsushita K, Ärnlöv J, et al. CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369:932–943.
  • Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312–318.
  • Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–226.
  • Sundin PO, Sjöström P, Jones I, et al. Measured GFR does not improve prediction of mortality by cystatin C and creatinine. Nephrol Dial Transplant. 2017;32:663–670.
  • Grubb A. Cystatin C is indispensable for evaluation of kidney disease. eJIFCC. 2017;28:269–276.
  • Tangri N, Inker LA, Tighiouart H, et al. Filtration markers may have prognostic value independent of glomerular filtration rate. JASN. 2012;23:351–359.
  • Christensson A, Ash JA, DeLisle RK, et al. The impact of the glomerular filtration rate on the human plasma proteome. Prot Clin Appl. 2018; 12:e1700067.
  • Nyman U, Björk J, Lindström V, et al. The Lund-Malmö creatinine-based glomerular filtration rate prediction equation for adults also performs well in children. Scand J Clin Lab Invest. 2008;68:568–576.
  • den Bakker E, Hubeek I, Stoffel-Wagner B, et al. “Das „Shrunken pore syndrome “– auch im Kindersalter?”“Nieren- und Hochdruckkrankheiten. 2017;46:9–10. Available from: https://docplayer.org/40832815-Issn-postvertriebsstueck-entgelt-bezahlt-b-1185-e-dustri-verlag-dr-karl-feistle-bajuwarenring-4-d-deisenhofen-oberhaching.html
  • den Bakker E, Gemke R, van Wijk J, et al. Evidence for shrunken pore syndrome in children. Scand J Clin Lab Invest. 2020;80:32–38.
  • Definition and classification of CKD. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:19–150.
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.